Drug class
C-type Natriuretic Peptide Analog
Mechanism of action
In patients with achondroplasia, endochondral bone growth is negatively regulated due to a gain of function mutation in fibroblast growth factor receptor 3 ( FGFR3 ).
General use cases
- Achondroplasia
- Dwarfism
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
